Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
DGAT2 is the critical catalyzing enzyme for triglyceride biosynthesis. Diacylglycerol acyltransferases (DGATs) play a crucial role in the biosynthesis of triacylglycerol (TG), which is the main storage form of metabolic energy in eukaryotic organisms. Although DGAT2, one of the two different DGATs, plays an important role in TG biosynthesis, little is known about the regulation of DGAT2 activity. Two different diacylglycerol acyltransferases (DGAT) - DGAT1 and DGAT2 - are involved in catalysing the final step of TG biosynthesis by forming a covalent bond between acyl CoA and diacylglycerol (DG). They are both primarily localized in the endoplasmic reticulum (ER), but DGAT2 is also associated with mitochondria and lipid droplets. DGAT2 is highly expressed in liver and adipose tissue and uses nascent DG and de-synthesised fatty acids as substrates to mediate another pathway called glycerophosphate.
Role of DGAT2 in Lipid Metabolism
Dietary lipids are absorbed into the intestinal epithelium as fatty acids and converted to triglycerides by diacylglycerol acyltransferase (DGAT), which are then packaged in celiac particles or stored in cytoplasmic lipid droplets (LDs). Patients deficient in DGAT1 experience vomiting, diarrhoea and protein-losing enteropathy, illustrating the importance of this process to intestinal homeostasis. DGAT1 deficiency leads to reduced LD formation in the intestinal organ tissues of patients and resistance to unsaturated fatty acid lipotoxicity. However, LD formation is not completely lost in patient-derived organ tissues, suggesting an alternative mechanism for LD formation. An unexpected role of DGAT2 in lipid metabolism is suggested, as DGAT2 partially compensates for LD formation and lipotoxicity in DGAT1-deficient intestinal stem cells. Furthermore, (un)saturated fatty acid-induced lipotoxicity is mediated by ER stress. More importantly, overexpression of DGAT2 fully compensated for DGAT1 deficiency in organ tissues, suggesting that induction of DGAT2 expression in patient cells could serve as a future therapeutic target.
Role of DGAT1 And DGAT2 in The Gut
Effects of DGAT1 and DGAT2-mediated lipid metabolism on intestinal epithelial cell homeostasis. Epithelial stem cells express both functional DGAT1 and DGAT2, although DGAT2 was previously expressed only at very low levels in the human intestine. Furthermore, functional expression of DGAT2 is lost upon differentiation towards the enterocyte phenotype and that DGAT2 partially compensates for LD formation and resistance to lipotoxicity when DGAT1 function is inhibited in intestinal stem cells. DGAT1-dependent OA-induced LD formation is tolerated in the absence of DGAT1, which is also partially dependent on DGAT2. In addition, the protective effect of LD is linked to an attenuation of the lipid-induced ER stress response. Finally, overexpression of DGAT2 completely attenuated OA-mediated lipotoxicity in patient-derived DGAT1-deficient enterocytes.
Role of Cysteine And Its Oxidation in Human DGAT2 Enzyme Activity In Vitro
Thiol-modifying reagents (NEM and IA) as well as ROS-related chemicals (H2O2 and β-lapachone) severely inhibit human DGAT2 activity, whereas human DGAT1 and GPAT1 are virtually unaffected. In particular, ROS-related chemicals simultaneously induced intermolecular disulfide cross-linking in human DGAT2. After treatment with the disulfide bond reducer DTT, the oxidative inactivation and disulfide cross-linking were almost completely reversed, suggesting that ROS-induced intermolecular cross-linking plays an important role in the inactivation of human DGAT2 and that DGAT2 is a redox-sensitive regulator of TG biosynthesis.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.